Tag: R3 Vascular

R3 Vascular

R3 Vascular secures WCG IRB approval and CMS category B Medicare...

R3 Vascular today announced that it has received WCG Institutional Review Board (IRB) approval for the ELITE-BTK pivotal trial of its Magnitude drug-eluting next-generation...
adverse

US FDA grants R3 Vascular IDE approval for ELITE-BTK pivotal trial...

R3 Vascular today announced that the US Food and Drug Administration (FDA) has granted the company investigational device exemption (IDE) approval to initiate its...
R3 Vascular

R3 Vascular reports the initiation of its first-in-human clinical study

R3 Vascular has reported the successful initiation of its first-in-human clinical study evaluating the technical and clinical performance of the R3 Vascular Magnitude bioresorbable...
R3 Vascular

R3 Vascular completes Series A financing

R3 Vascular recently announced closing of its Series A financing round, including new equity investments of US$15 million and the conversion of US$2.8 million...